CTOs on the Move

Central Georgia Health Network

www.mycghn.com

 
CGHN has been a trusted partner for Central Georgia independent physicians for over 20 years, with proven success in favorable payouts, dividends and contracting. This commitment to physician independence is at the very heart of CGHN`s identity. CGHN`s ownership structure ensures independent physicians in Central Georgia maintain a strong, controlling governance voice. CGHN is a growing, clinically-integrated network representing nearly 1,000 independent physicians, healthcare professionals and hospital partners across Central Georgia. Our goal is to deliver the best patient care experiences, while enhancing care quality and lowering costs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mycghn.com
  • 111 Perimeter Parkway
    Macon, GA USA 31210
  • Phone: 478.832.6134

Executives

Name Title Contact Details
Gabriel Orthous
Chief Information Officer Profile

Similar Companies

Holly Hill Manor

Holly Hill Manor is a Towson, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ampio Pharmaceuticals

Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates.  These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending.  Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™.  The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.  Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema.  Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.

Medical Information Technology, Inc.

Medical Information Technology, Inc. (MEDITECH) is engaged in developing, manufacturing and marketing of computer software products for the hospital industry. The wholly owned subsidiary of the Company is Patient Care Technologies, Inc. (PtCT).

Deltex Medical

Deltex Medical is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.